​

Verrica Pharmaceuticals (VRCA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Verrica Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$7.57M

Latest Revenue (Q)

$12.70M

Main Segment (Y)

Product

Verrica Pharmaceuticals Revenue by Period

Verrica Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$7.57M47.66%
2023-12-31$5.12M-43.27%
2022-12-31$9.03M-24.73%
2021-12-31$12.00M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

Verrica Pharmaceuticals generated $7.57M in revenue during NA 2024, up 47.66% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Verrica Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-06-30$12.70M269.35%
2025-03-31$3.44M899.71%
2024-12-31$344.00K-119.31%
2024-09-30$-1.78M-134.40%
2024-06-30$5.18M35.31%
2024-03-31$3.83M92.45%
2023-12-31$1.99M-31.85%
2023-09-30$2.92M1502.75%
2023-06-30$182.00K391.89%
2023-03-31$37.00K-45.59%
2022-12-31$68.00K-99.18%
2022-09-30$8.32M3787.38%
2022-06-30$214.00K-50.35%
2022-03-31$431.00K-103.59%
2021-12-31$-12.00M100.00%
2021-09-30-100.00%
2021-06-30--100.00%
2021-03-31$12.00M100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Verrica Pharmaceuticals generated $12.70M in revenue during Q2 2025, up 269.35% compared to the previous quarter, and up 331.99% compared to the same period a year ago.

Verrica Pharmaceuticals Revenue Breakdown

Verrica Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23
Collaboration$992.00K$466.00K
Product$6.57M$4.66M

Verrica Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (86.89%), and Collaboration (13.11%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25Dec 24Sep 24Jun 24Mar 24
Product$4.53M$3.42M$315.00K$-1.86M$4.89M$3.23M
License And Collaboration Revenue$8.17M-----
Collaboration-$17.00K$29.00K$84.00K$285.00K$594.00K

Verrica Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: License And Collaboration Revenue (64.30%), and Product (35.70%).

Verrica Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
FGENFibroGen$29.62M$1.35M
LVTXLAVA Therapeutics$11.98M-
VRCAVerrica Pharmaceuticals$7.57M$12.70M
XLOXilio Therapeutics$6.34M$1.72M
EYENEyenovia$57.34K$14.72K
APLMApollomics--
OKUROnKure Therapeutics--
MURAMural Oncology--
RANIRani Therapeutics--
JSPRJasper Therapeutics--
PSTVPlus Therapeutics-$1.06M

VRCA Revenue FAQ

What is Verrica Pharmaceuticals’s yearly revenue?

Verrica Pharmaceuticals's yearly revenue for 2024 was $7.57M, representing an increase of 47.66% compared to 2023. The company's yearly revenue for 2023 was $5.12M, representing a decrease of -43.27% compared to 2022. VRCA's yearly revenue for 2022 was $9.03M, representing a decrease of -24.73% compared to 2021.

What is Verrica Pharmaceuticals’s quarterly revenue?

Verrica Pharmaceuticals's quarterly revenue for Q2 2025 was $12.7M, a 269.35% increase from the previous quarter (Q1 2025), and a 145.35% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $3.44M, a 899.71% increase from the previous quarter (Q4 2024), and a -10.12% decrease year-over-year (Q1 2024). VRCA's quarterly revenue for Q4 2024 was $344K, a -119.31% decrease from the previous quarter (Q3 2024), and a -82.70% decrease year-over-year (Q4 2023).

What is Verrica Pharmaceuticals’s revenue growth rate?

Verrica Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was -16.23%, and for the last 5 years (2020-2024) was 0%.

What are Verrica Pharmaceuticals’s revenue streams?

Verrica Pharmaceuticals's revenue streams in c 24 are Collaboration, and Product. Collaboration generated $992K in revenue, accounting 13.11% of the company's total revenue, up 112.88% year-over-year. Product generated $6.57M in revenue, accounting 86.89% of the company's total revenue, up 41.13% year-over-year.

What is Verrica Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Verrica Pharmaceuticals was Product. This segment made a revenue of $6.57M, representing 86.89% of the company's total revenue.